Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670124 · ClinicalTrials.gov registry record · NA
Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver Failure
A NA study, sponsored by Rigshospitalet, Denmark.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00670124 is a NA study that has completed, run by Rigshospitalet, Denmark. The registered enrollment target is 50 participants.
The verdict
NCT00670124, a NA study, has completed, sponsored by Rigshospitalet, Denmark.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Treatment options in patients with high intracranial pressure due to acute liver failure are limited. This study intends to evaluate the effect of prophylactic hypothermia on preventing high intracranial pressure and compromised cerebral oxidative metabolism.
Interventions
- DEVICE Hypothermia by the use of Blanketrol II, Cincinnati Sub-Zero
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00670124
The ClinicalTrials.gov registry entry for NCT00670124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rigshospitalet, Denmark, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypothermia by the use of Blanketrol II, Cincinnati Sub-Zero is the first listed.
NCT00670124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00670124 about?
NCT00670124 is a clinical study titled "Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver Failure". Treatment options in patients with high intracranial pressure due to acute liver failure are limited. This study intends to evaluate the effect of prophylactic hypothermia on preventing high intracranial pressure and compromised cerebral oxidative metabolism.
What is the current status of trial NCT00670124?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2005-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00670124?
The interventions under investigation include: Hypothermia by the use of Blanketrol II, Cincinnati Sub-Zero (DEVICE).
Who is sponsoring clinical trial NCT00670124?
This trial is sponsored by Rigshospitalet, Denmark, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.